Global Dermal Fillers Facial Aesthetics Market By Type (HA Dermal Fillers {Monophasic HA Fillers, Biphasic HA Fillers}, Non-HA Dermal Fillers {Polymethylmethacrylate (PMMA) Filler, Collagen, Poly-L-Lactic Acid (PLLA), Calcium Hydroxylapatite (CaHA)}), By Application (Wrinkles, Lip Enhancement, Facial Contouring, Glabellar Furrows, Peri-Orbital, Others (Scars, Crow's Feet, Etc.) By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Portugal, Poland, Nordic { Denmark, Finland, Iceland, Norway, Sweden, Rest of Nordic}, Ukraine, The Benelux Union {Belgium, the Netherlands, Luxemburg}, Rest of Europe, China, Japan, India, Australia, New Zealand, Hong Kong, Singapore, Taiwan, Malaysia, Russia, Southeast Asia, Rest of Asia Pacific, GCC Countries, UAE, Saudi Arabia, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027

Report ID :AMI-161 | Category : Healthcare | Published Date : February, 2019 | Pages : 402 | Format :PDF
Buy Now!

Industry Trends:

Global dermal fillers facial aesthetics market is growing exponentially among the consumers owing to favorable factors such as lack of down time, quick procedure time and long lasting results. The adoption of these non-surgical treatments tend to be cost-effective in nature compared to surgery. These facial injectable are used to contour the face and give a youthful appearance. Types of the same includes lip filler, nose filler, jawline filler, cheek filler and tear trough amongst others. The American Society of Aesthetic Plastic Surgery reported that more than 2.4 million people opted for hyaluronic acid filler treatment in 2016. Bioengineered human collagen products coupled with different types of hyaluronic acid are considered to be safe and effective at the same time for soft tissue augmentation. In the recent past, hyaluronic acid constituted 90% of the global filler industry.   However, the complications associated with the HA injection tend to increase causing inflammatory reactions on the skin. Doppler ultrasound (duplex) is used in dermatology application for evaluating the dermatological conditions of the skin and vascular structures. It mainly helps in improving the safety of hyaluronic acid filler injections.

The dermal fillers approved by the US Food and Drug Administration includes Belotero, Restylane, Voluma, Radiesse, Juvederm Vollure and Juvederm Voluma amongst others. For instance, Juvederm is a dermal filler type used for facial wrinkle treatment. The ingredients of the same mainly include water and hyaluronic acid to create a gel-like product that plumps up the skin. The average cost for each syringe is US$ 620. However, the cost varies in accordance with the different formulas of the product. Each of the Juvederm formula type is available in “XC” version containing lidocaine. This tends to make the injections less painful in nature.

Global dermal fillers facial aesthetics market was valued at USD 5348.98 million in 2018. The study analyzes the market in terms of revenue, production and sales volume across all the major markets.

North America Dermal Fillers Facial Aesthetics Market Sales, 2019 - 2027

Global dermal fillers facial aesthetics.jpg

 

Competitive Landscape

The report provides both, qualitative and quantitative research of global dermal fillers facial aesthetics market, as well as provides worthy insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in global dermal fillers facial aesthetics market and detailed insights on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarter, competitors, product/service type, application and specification, pricing, and gross margin.

Dermal Fillers Facial Aesthetics Market participants include Bloomage BioTechnology Corporation Limited, LG Lifesciences, SciVision Biotech Inc., Luminera Derm Ltd, Hangzhou Singclean Medical Products Co.,Ltd, Bohus BioTech AB, Matex Lab SA (Neauvia), Suneva Medical, Inc., DR. Korman, Sinclair Pharma, TEOXANE Laboratories, Merz Pharma, Galderma S.A., Allergan Plc. amongst others.

By Type

  • HA Dermal Fillers
    • Monophasic HA Fillers
    • Biphasic HA Fillers
  • Non-HA Dermal Fillers
    • Polymethylmethacrylate (PMMA) Filler
    • Collagen
    • Poly-L-Lactic Acid (PLLA)
    • Calcium Hydroxylapatite (CaHA)

By Application

  • Wrinkles
  • Lip Enhancement
  • Facial Contouring
  • Glabellar Furrows
  • Peri-Orbital
  • Others (Scars, Crow's Feet, Etc.)

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Key Questions

Request Sample

Report Customization

Request for Customization

1.    Market Scope

1.1.   Market Segmentation

1.2.   Years Considered

1.2.1. Historic Years: 2013 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

1.3.   Methodology

1.4.   Assumptions

2.    Key Target Audience

3.    Research Methodology

3.1.   Primary Research

3.1.1. Research Questionnaire

3.1.2. Country-Wise Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2.   Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3.   Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4.   Data Triangulation Methodology

3.5.   Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of Dermal Fillers Facial Aesthetics Market

6.    Market Synopsis:  Dermal Fillers Facial Aesthetics Market

7.    Dermal Fillers Facial Aesthetics Market: Qualitative Perspective

7.1.   Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2.   Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3.   Trends in Dermal Fillers Facial Aesthetics Market

7.4.   Market Determinants Radar Chart

7.5.   Macro-Economic and Micro-Economic Indicators: Dermal Fillers Facial Aesthetics Market

7.6.   Industry Gross Margin Overview

7.7.   PESTEL Analysis

7.8.   Injection Technique: Dermal Fillers Facial Aesthetics Market

7.9.   Porter’s Five Forces Analysis

7.10. Value Chain Analysis

7.11. Pricing Analysis, By Region (2017 and 2018)

7.11.1. North America

7.11.1.1. U.S

7.11.1.2. Canada

7.11.1.3. Mexico

7.11.2. Europe

7.11.2.1. France

7.11.2.2. The UK

7.11.2.3. Spain

7.11.2.4. Germany

7.11.2.5. Italy

7.11.2.6. Poland

7.11.2.7. Denmark

7.11.2.8. Finland

7.11.2.9. Iceland

7.11.2.10. Norway

7.11.2.11. Sweden

7.11.2.12. Russia

7.11.2.13. Ukraine

7.11.2.14. Belgium

7.11.2.15. The Netherlands

7.11.2.16. Luxembourg

7.11.3. Asia Pacific

7.11.3.1. China

7.11.3.2. Japan

7.11.3.3. India

7.11.3.4. New Zealand

7.11.3.5. Malaysia

7.11.3.6. Taiwan

7.11.3.7. Russia

7.11.3.8. Singapore

7.11.3.9. Hong Kong

7.11.3.10. Australia

7.11.3.11. Southeast Asia

7.11.4. Middle East and Africa

7.11.4.1. GCC Countries

7.11.4.2. UAE

7.11.4.3. Saudi Arabia

7.11.4.4. Southern Africa

7.11.5. Latin America

7.11.5.1. Brazil

7.11.5.2. Argentina

7.12. Marketing Channel, Dermal Fillers Facial Aesthetics Market

7.12.1. Direct Marketing

7.12.2. Indirect Marketing

7.12.3. Marketing Channel Development Trend

7.13. Market Positioning, Dermal Fillers Facial Aesthetics Market

7.13.1. Pricing Strategy

7.13.2. Brand Strategy

7.13.3. Target Client

8.    Global Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

8.1.   Overview

8.1.1. Global Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts

8.2.   Global Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

8.2.1. HA Dermal Fillers

8.2.1.1. Definition

8.2.1.2. Market Penetration, 2018

8.2.1.3. Market Estimation, 2013 – 2018

8.2.1.4. Market Forecast, 2019 – 2027

8.2.1.5. Compound Annual Growth Rate (CAGR)

8.2.1.6. Regional Bifurcation

8.2.1.6.1. North America

8.2.1.6.1.1. Market Estimation, 2013 – 2018

8.2.1.6.1.2. Market Forecast, 2019 – 2027

8.2.1.6.2. Europe

8.2.1.6.2.1. Market Estimation, 2013 – 2018

8.2.1.6.2.2. Market Forecast, 2019 – 2027

8.2.1.6.3. Asia Pacific

8.2.1.6.3.1. Market Estimation, 2013 – 2018

8.2.1.6.3.2. Market Forecast, 2019 – 2027

8.2.1.6.4. Middle East and Africa

8.2.1.6.4.1. Market Estimation, 2013 – 2018

8.2.1.6.4.2. Market Forecast, 2019 – 2027

8.2.1.6.5. Latin America

8.2.1.6.5.1. Market Estimation, 2013 – 2018

8.2.1.6.5.2. Market Forecast, 2019 – 2027

8.2.1.7. Monophasic HA Fillers

8.2.1.7.1. Definition

8.2.1.7.2. Market Penetration, 2018

8.2.1.7.3. Market Estimation, 2013 – 2018

8.2.1.7.4. Market Forecast, 2019 – 2027

8.2.1.7.5. Compound Annual Growth Rate (CAGR)

8.2.1.7.6. Regional Bifurcation

8.2.1.7.7. North America

8.2.1.7.7.1. Market Estimation, 2013 – 2018

8.2.1.7.7.2. Market Forecast, 2019 – 2027

8.2.1.7.8. Europe

8.2.1.7.8.1. Market Estimation, 2013 – 2018

8.2.1.7.8.2. Market Forecast, 2019 – 2027

8.2.1.7.9. Asia Pacific

8.2.1.7.9.1. Market Estimation, 2013 – 2018

8.2.1.7.9.2. Market Forecast, 2019 – 2027

8.2.1.7.10. Middle East and Africa

8.2.1.7.10.1. Market Estimation, 2013 – 2018

8.2.1.7.10.2. Market Forecast, 2019 – 2027

8.2.1.7.11. Latin America

8.2.1.7.11.1. Market Estimation, 2013 – 2018

8.2.1.7.11.2. Market Forecast, 2019 – 2027

8.2.1.8. Biphasic HA Fillers

8.2.1.8.1. Definition

8.2.1.8.2. Market Penetration, 2018

8.2.1.8.3. Market Estimation, 2013 – 2018

8.2.1.8.4. Market Forecast, 2019 – 2027

8.2.1.8.5. Compound Annual Growth Rate (CAGR)

8.2.1.8.6. Regional Bifurcation

8.2.1.8.7. North America

8.2.1.8.7.1. Market Estimation, 2013 – 2018

8.2.1.8.7.2. Market Forecast, 2019 – 2027

8.2.1.8.8. Europe

8.2.1.8.8.1. Market Estimation, 2013 – 2018

8.2.1.8.8.2. Market Forecast, 2019 – 2027

8.2.1.8.9. Asia Pacific

8.2.1.8.9.1. Market Estimation, 2013 – 2018

8.2.1.8.9.2. Market Forecast, 2019 – 2027

8.2.1.8.10. Middle East and Africa

8.2.1.8.10.1. Market Estimation, 2013 – 2018

8.2.1.8.10.2. Market Forecast, 2019 – 2027

8.2.1.8.11. Latin America

8.2.1.8.11.1. Market Estimation, 2013 – 2018

8.2.1.8.11.2. Market Forecast, 2019 – 2027

8.2.2. Non-HA Dermal Fillers

8.2.2.1. Definition

8.2.2.2. Market Penetration, 2018

8.2.2.3. Market Estimation, 2013 – 2018

8.2.2.4. Market Forecast, 2019 – 2027

8.2.2.5. Compound Annual Growth Rate (CAGR)

8.2.2.6. Regional Bifurcation

8.2.2.6.1. North America

8.2.2.6.1.1. Market Estimation, 2013 – 2018

8.2.2.6.1.2. Market Forecast, 2019 – 2027

8.2.2.6.2. Europe

8.2.2.6.2.1. Market Estimation, 2013 – 2018

8.2.2.6.2.2. Market Forecast, 2019 – 2027

8.2.2.6.3. Asia Pacific

8.2.2.6.3.1. Market Estimation, 2013 – 2018

8.2.2.6.3.2. Market Forecast, 2019 – 2027

8.2.2.6.4. Middle East and Africa

8.2.2.6.4.1. Market Estimation, 2013 – 2018

8.2.2.6.4.2. Market Forecast, 2019 – 2027

8.2.2.6.5. Latin America

8.2.2.6.5.1. Market Estimation, 2013 – 2018

8.2.2.6.5.2. Market Forecast, 2019 – 2027

8.2.2.7. Polymethylmethacrylate (PMMA) Filler

8.2.2.7.1. Definition

8.2.2.7.2. Market Penetration, 2018

8.2.2.7.3. Market Estimation, 2013 – 2018

8.2.2.7.4. Market Forecast, 2019 – 2027

8.2.2.7.5. Compound Annual Growth Rate (CAGR)

8.2.2.7.6. Regional Bifurcation

8.2.2.7.7. North America

8.2.2.7.7.1. Market Estimation, 2013 – 2018

8.2.2.7.7.2. Market Forecast, 2019 – 2027

8.2.2.7.8. Europe

8.2.2.7.8.1. Market Estimation, 2013 – 2018

8.2.2.7.8.2. Market Forecast, 2019 – 2027

8.2.2.7.9. Asia Pacific

8.2.2.7.9.1. Market Estimation, 2013 – 2018

8.2.2.7.9.2. Market Forecast, 2019 – 2027

8.2.2.7.10. Middle East and Africa

8.2.2.7.10.1. Market Estimation, 2013 – 2018

8.2.2.7.10.2. Market Forecast, 2019 – 2027

8.2.2.7.11. Latin America

8.2.2.7.11.1. Market Estimation, 2013 – 2018

8.2.2.7.11.2. Market Forecast, 2019 – 2027

8.2.2.8. Collagen

8.2.2.8.1. Definition

8.2.2.8.2. Market Penetration, 2018

8.2.2.8.3. Market Estimation, 2013 – 2018

8.2.2.8.4. Market Forecast, 2019 – 2027

8.2.2.8.5. Compound Annual Growth Rate (CAGR)

8.2.2.8.6. Regional Bifurcation

8.2.2.8.7. North America

8.2.2.8.7.1. Market Estimation, 2013 – 2018

8.2.2.8.7.2. Market Forecast, 2019 – 2027

8.2.2.8.8. Europe

8.2.2.8.8.1. Market Estimation, 2013 – 2018

8.2.2.8.8.2. Market Forecast, 2019 – 2027

8.2.2.8.9. Asia Pacific

8.2.2.8.9.1. Market Estimation, 2013 – 2018

8.2.2.8.9.2. Market Forecast, 2019 – 2027

8.2.2.8.10. Middle East and Africa

8.2.2.8.10.1. Market Estimation, 2013 – 2018

8.2.2.8.10.2. Market Forecast, 2019 – 2027

8.2.2.8.11. Latin America

8.2.2.8.11.1. Market Estimation, 2013 – 2018

8.2.2.8.11.2. Market Forecast, 2019 – 2027

8.2.2.9. Poly-L-Lactic Acid (PLLA)

8.2.2.9.1. Definition

8.2.2.9.2. Market Penetration, 2018

8.2.2.9.3. Market Estimation, 2013 – 2018

8.2.2.9.4. Market Forecast, 2019 – 2027

8.2.2.9.5. Compound Annual Growth Rate (CAGR)

8.2.2.9.6. Regional Bifurcation

8.2.2.9.7. North America

8.2.2.9.7.1. Market Estimation, 2013 – 2018

8.2.2.9.7.2. Market Forecast, 2019 – 2027

8.2.2.9.8. Europe

8.2.2.9.8.1. Market Estimation, 2013 – 2018

8.2.2.9.8.2. Market Forecast, 2019 – 2027

8.2.2.9.9. Asia Pacific

8.2.2.9.9.1. Market Estimation, 2013 – 2018

8.2.2.9.9.2. Market Forecast, 2019 – 2027

8.2.2.9.10. Middle East and Africa

8.2.2.9.10.1. Market Estimation, 2013 – 2018

8.2.2.9.10.2. Market Forecast, 2019 – 2027

8.2.2.9.11. Latin America

8.2.2.9.11.1. Market Estimation, 2013 – 2018

8.2.2.9.11.2. Market Forecast, 2019 – 2027

8.2.2.10. Calcium Hydroxylapatite (CaHA)

8.2.2.10.1. Definition

8.2.2.10.2. Market Penetration, 2018

8.2.2.10.3. Market Estimation, 2013 – 2018

8.2.2.10.4. Market Forecast, 2019 – 2027

8.2.2.10.5. Compound Annual Growth Rate (CAGR)

8.2.2.10.6. Regional Bifurcation

8.2.2.10.7. North America

8.2.2.10.7.1. Market Estimation, 2013 – 2018

8.2.2.10.7.2. Market Forecast, 2019 – 2027

8.2.2.10.8. Europe

8.2.2.10.8.1. Market Estimation, 2013 – 2018

8.2.2.10.8.2. Market Forecast, 2019 – 2027

8.2.2.10.9. Asia Pacific

8.2.2.10.9.1. Market Estimation, 2013 – 2018

8.2.2.10.9.2. Market Forecast, 2019 – 2027

8.2.2.10.10. Middle East and Africa

8.2.2.10.10.1. Market Estimation, 2013 – 2018

8.2.2.10.10.2. Market Forecast, 2019 – 2027

8.2.2.10.11. Latin America

8.2.2.10.11.1. Market Estimation, 2013 – 2018

8.2.2.10.11.2. Market Forecast, 2019 – 2027

8.3.   Key Segment for Channeling Investments

8.3.1. By Type

9.    Global Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

9.1.   Overview

9.2.   Global Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

9.2.1. Wrinkles

9.2.1.1. Definition

9.2.1.2. Market Penetration, 2018

9.2.1.3. Market Estimation, 2013 – 2018

9.2.1.4. Market Forecast, 2019 – 2027

9.2.1.5. Compound Annual Growth Rate (CAGR)

9.2.1.6. Regional Bifurcation

9.2.1.6.1. North America

9.2.1.6.1.1. Market Estimation, 2013 – 2018

9.2.1.6.1.2. Market Forecast, 2019 – 2027

9.2.1.6.2. Europe

9.2.1.6.2.1. Market Estimation, 2013 – 2018

9.2.1.6.2.2. Market Forecast, 2019 – 2027

9.2.1.6.3. Asia Pacific

9.2.1.6.3.1. Market Estimation, 2013 – 2018

9.2.1.6.3.2. Market Forecast, 2019 – 2027

9.2.1.6.4. Middle East and Africa

9.2.1.6.4.1. Market Estimation, 2013 – 2018

9.2.1.6.4.2. Market Forecast, 2019 – 2027

9.2.1.6.5. Latin America

9.2.1.6.5.1. Market Estimation, 2013 – 2018

9.2.1.6.5.2. Market Forecast, 2019 – 2027

9.2.2. Lip Enhancement

9.2.2.1. Definition

9.2.2.2. Market Penetration, 2018

9.2.2.3. Market Estimation, 2013 – 2018

9.2.2.4. Market Forecast, 2019 – 2027

9.2.2.5. Compound Annual Growth Rate (CAGR)

9.2.2.6. Regional Bifurcation

9.2.2.6.1. North America

9.2.2.6.1.1. Market Estimation, 2013 – 2018

9.2.2.6.1.2. Market Forecast, 2019 – 2027

9.2.2.6.2. Europe

9.2.2.6.2.1. Market Estimation, 2013 – 2018

9.2.2.6.2.2. Market Forecast, 2019 – 2027

9.2.2.6.3. Asia Pacific

9.2.2.6.3.1. Market Estimation, 2013 – 2018

9.2.2.6.3.2. Market Forecast, 2019 – 2027

9.2.2.6.4. Middle East and Africa

9.2.2.6.4.1. Market Estimation, 2013 – 2018

9.2.2.6.4.2. Market Forecast, 2019 – 2027

9.2.2.6.5. Latin America

9.2.2.6.5.1. Market Estimation, 2013 – 2018

9.2.2.6.5.2. Market Forecast, 2019 – 2027

9.2.3. Facial Contouring

9.2.3.1. Definition

9.2.3.2. Market Penetration, 2018

9.2.3.3. Market Estimation, 2013 – 2018

9.2.3.4. Market Forecast, 2019 – 2027

9.2.3.5. Compound Annual Growth Rate (CAGR)

9.2.3.6. Regional Bifurcation

9.2.3.6.1. North America

9.2.3.6.1.1. Market Estimation, 2013 – 2018

9.2.3.6.1.2. Market Forecast, 2019 – 2027

9.2.3.6.2. Europe

9.2.3.6.2.1. Market Estimation, 2013 – 2018

9.2.3.6.2.2. Market Forecast, 2019 – 2027

9.2.3.6.3. Asia Pacific

9.2.3.6.3.1. Market Estimation, 2013 – 2018

9.2.3.6.3.2. Market Forecast, 2019 – 2027

9.2.3.6.4. Middle East and Africa

9.2.3.6.4.1. Market Estimation, 2013 – 2018

9.2.3.6.4.2. Market Forecast, 2019 – 2027

9.2.3.6.5. Latin America

9.2.3.6.5.1. Market Estimation, 2013 – 2018

9.2.3.6.5.2. Market Forecast, 2019 – 2027

9.2.4. Glabellar Furrows

9.2.4.1. Definition

9.2.4.2. Market Penetration, 2018

9.2.4.3. Market Estimation, 2013 – 2018

9.2.4.4. Market Forecast, 2019 – 2027

9.2.4.5. Compound Annual Growth Rate (CAGR)

9.2.4.6. Regional Bifurcation

9.2.4.6.1. North America

9.2.4.6.1.1. Market Estimation, 2013 – 2018

9.2.4.6.1.2. Market Forecast, 2019 – 2027

9.2.4.6.2. Europe

9.2.4.6.2.1. Market Estimation, 2013 – 2018

9.2.4.6.2.2. Market Forecast, 2019 – 2027

9.2.4.6.3. Asia Pacific

9.2.4.6.3.1. Market Estimation, 2013 – 2018

9.2.4.6.3.2. Market Forecast, 2019 – 2027

9.2.4.6.4. Middle East and Africa

9.2.4.6.4.1. Market Estimation, 2013 – 2018

9.2.4.6.4.2. Market Forecast, 2019 – 2027

9.2.4.6.5. Latin America

9.2.4.6.5.1. Market Estimation, 2013 – 2018

9.2.4.6.5.2. Market Forecast, 2019 – 2027

9.2.5. Peri-Orbital

9.2.5.1. Definition

9.2.5.2. Market Penetration, 2018

9.2.5.3. Market Estimation, 2013 – 2018

9.2.5.4. Market Forecast, 2019 – 2027

9.2.5.5. Compound Annual Growth Rate (CAGR)

9.2.5.6. Regional Bifurcation

9.2.5.6.1. North America

9.2.5.6.1.1. Market Estimation, 2013 – 2018

9.2.5.6.1.2. Market Forecast, 2019 – 2027

9.2.5.6.2. Europe

9.2.5.6.2.1. Market Estimation, 2013 – 2018

9.2.5.6.2.2. Market Forecast, 2019 – 2027

9.2.5.6.3. Asia Pacific

9.2.5.6.3.1. Market Estimation, 2013 – 2018

9.2.5.6.3.2. Market Forecast, 2019 – 2027

9.2.5.6.4. Middle East and Africa

9.2.5.6.4.1. Market Estimation, 2013 – 2018

9.2.5.6.4.2. Market Forecast, 2019 – 2027

9.2.5.6.5. Latin America

9.2.5.6.5.1. Market Estimation, 2013 – 2018

9.2.5.6.5.2. Market Forecast, 2019 – 2027

9.2.6. Others (Scars, Crow’s Feet, Etc.)

9.2.6.1. Definition

9.2.6.2. Market Penetration, 2018

9.2.6.3. Market Estimation, 2013 – 2018

9.2.6.4. Market Forecast, 2019 – 2027

9.2.6.5. Compound Annual Growth Rate (CAGR)

9.2.6.6. Regional Bifurcation

9.2.6.6.1. North America

9.2.6.6.1.1. Market Estimation, 2013 – 2018

9.2.6.6.1.2. Market Forecast, 2019 – 2027

9.2.6.6.2. Europe

9.2.6.6.2.1. Market Estimation, 2013 – 2018

9.2.6.6.2.2. Market Forecast, 2019 – 2027

9.2.6.6.3. Asia Pacific

9.2.6.6.3.1. Market Estimation, 2013 – 2018

9.2.6.6.3.2. Market Forecast, 2019 – 2027

9.2.6.6.4. Middle East and Africa

9.2.6.6.4.1. Market Estimation, 2013 – 2018

9.2.6.6.4.2. Market Forecast, 2019 – 2027

9.2.6.6.5. Latin America

9.2.6.6.5.1. Market Estimation, 2013 – 2018

9.2.6.6.5.2. Market Forecast, 2019 – 2027

9.3.   Key Segment for Channeling Investments

9.3.1. By Application

10. North America Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

10.1. Overview

10.1.1. North America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)

10.2. North America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

10.2.1. HA Dermal Fillers

10.2.1.1. Monophasic HA Fillers

10.2.1.2. Biphasic HA Fillers

10.2.2. Non-HA Dermal Fillers

10.2.2.1. Polymethylmethacrylate (PMMA) Filler

10.2.2.2. Collagen

10.2.2.3. Poly-L-Lactic Acid (PLLA)

10.2.2.4. Calcium Hydroxylapatite (CaHA)

10.3. North America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

10.3.1. Wrinkles

10.3.2. Lip Enhancement

10.3.3. Facial Contouring

10.3.4. Glabellar Furrows

10.3.5. Peri-Orbital

10.3.6. Others (Scars, Crow’s Feet, Etc.)

10.4. North America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

10.4.1. U.S.

10.4.1.1. U.S. Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

10.4.1.1.1. HA Dermal Fillers

10.4.1.1.1.1. Monophasic HA Fillers

10.4.1.1.1.2. Biphasic HA Fillers

10.4.1.1.2. Non-HA Dermal Fillers

10.4.1.1.2.1. Polymethylmethacrylate (PMMA) Filler

10.4.1.1.2.2. Collagen

10.4.1.1.2.3. Poly-L-Lactic Acid (PLLA)

10.4.1.1.2.4. Calcium Hydroxylapatite (CaHA)

10.4.1.2. U.S. Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

10.4.1.2.1. Wrinkles

10.4.1.2.2. Lip Enhancement

10.4.1.2.3. Facial Contouring

10.4.1.2.4. Glabellar Furrows

10.4.1.2.5. Peri-Orbital

10.4.1.2.6. Others (Scars, Crow’s Feet, Etc.)

10.4.2. Canada

10.4.2.1. Canada Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

10.4.2.1.1. HA Dermal Fillers

10.4.2.1.1.1. Monophasic HA Fillers

10.4.2.1.1.2. Biphasic HA Fillers

10.4.2.1.2. Non-HA Dermal Fillers

10.4.2.1.2.1. Polymethylmethacrylate (PMMA) Filler

10.4.2.1.2.2. Collagen

10.4.2.1.2.3. Poly-L-Lactic Acid (PLLA)

10.4.2.1.2.4. Calcium Hydroxylapatite (CaHA)

10.4.2.2. Canada Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

10.4.2.2.1. Wrinkles

10.4.2.2.2. Lip Enhancement

10.4.2.2.3. Facial Contouring

10.4.2.2.4. Glabellar Furrows

10.4.2.2.5. Peri-Orbital

10.4.2.2.6. Others (Scars, Crow’s Feet, Etc.)

10.4.3. Mexico

10.4.3.1. Mexico Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

10.4.3.1.1. HA Dermal Fillers

10.4.3.1.1.1. Monophasic HA Fillers

10.4.3.1.1.2. Biphasic HA Fillers

10.4.3.1.2. Non-HA Dermal Fillers

10.4.3.1.2.1. Polymethylmethacrylate (PMMA) Filler

10.4.3.1.2.2. Collagen

10.4.3.1.2.3. Poly-L-Lactic Acid (PLLA)

10.4.3.1.2.4. Calcium Hydroxylapatite (CaHA)

10.4.3.2. Mexico Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

10.4.3.2.1. Wrinkles

10.4.3.2.2. Lip Enhancement

10.4.3.2.3. Facial Contouring

10.4.3.2.4. Glabellar Furrows

10.4.3.2.5. Peri-Orbital

10.4.3.2.6. Others (Scars, Crow’s Feet, Etc.)

10.4.4. Rest of North America

10.4.4.1. Rest of North America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

10.4.4.1.1. HA Dermal Fillers

10.4.4.1.1.1. Monophasic HA Fillers

10.4.4.1.1.2. Biphasic HA Fillers

10.4.4.1.2. Non-HA Dermal Fillers

10.4.4.1.2.1. Polymethylmethacrylate (PMMA) Filler

10.4.4.1.2.2. Collagen

10.4.4.1.2.3. Poly-L-Lactic Acid (PLLA)

10.4.4.1.2.4. Calcium Hydroxylapatite (CaHA)

10.4.4.2. Rest of North America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

10.4.4.2.1. Wrinkles

10.4.4.2.2. Lip Enhancement

10.4.4.2.3. Facial Contouring

10.4.4.2.4. Glabellar Furrows

10.4.4.2.5. Peri-Orbital

10.4.4.2.6. Others (Scars, Crow’s Feet, Etc.)

10.5. Key Segment for Channeling Investments

10.5.1. By Country

10.5.2. By Type

10.5.3. By Application

11. Europe Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

11.1. Overview

11.1.1. Europe Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)

11.2. Europe Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.2.1. HA Dermal Fillers

11.2.1.1. Monophasic HA Fillers

11.2.1.2. Biphasic HA Fillers

11.2.2. Non-HA Dermal Fillers

11.2.2.1. Polymethylmethacrylate (PMMA) Filler

11.2.2.2. Collagen

11.2.2.3. Poly-L-Lactic Acid (PLLA)

11.2.2.4. Calcium Hydroxylapatite (CaHA)

11.3. Europe Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.3.1. Wrinkles

11.3.2. Lip Enhancement

11.3.3. Facial Contouring

11.3.4. Glabellar Furrows

11.3.5. Peri-Orbital

11.3.6. Others (Scars, Crow’s Feet, Etc.)

11.4. Europe Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

11.4.1. France

11.4.1.1. France Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.1.1.1. HA Dermal Fillers

11.4.1.1.1.1. Monophasic HA Fillers

11.4.1.1.1.2. Biphasic HA Fillers

11.4.1.1.2. Non-HA Dermal Fillers

11.4.1.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.1.1.2.2. Collagen

11.4.1.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.1.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.1.2. France Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.1.2.1. Wrinkles

11.4.1.2.2. Lip Enhancement

11.4.1.2.3. Facial Contouring

11.4.1.2.4. Glabellar Furrows

11.4.1.2.5. Peri-Orbital

11.4.1.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.2. The UK

11.4.2.1. The UK Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.2.1.1. HA Dermal Fillers

11.4.2.1.1.1. Monophasic HA Fillers

11.4.2.1.1.2. Biphasic HA Fillers

11.4.2.1.2. Non-HA Dermal Fillers

11.4.2.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.2.1.2.2. Collagen

11.4.2.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.2.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.2.2. The UK Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.2.2.1. Wrinkles

11.4.2.2.2. Lip Enhancement

11.4.2.2.3. Facial Contouring

11.4.2.2.4. Glabellar Furrows

11.4.2.2.5. Peri-Orbital

11.4.2.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.3. Spain

11.4.3.1. Spain Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.3.1.1. HA Dermal Fillers

11.4.3.1.1.1. Monophasic HA Fillers

11.4.3.1.1.2. Biphasic HA Fillers

11.4.3.1.2. Non-HA Dermal Fillers

11.4.3.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.3.1.2.2. Collagen

11.4.3.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.3.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.3.2. Spain Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.3.2.1. Wrinkles

11.4.3.2.2. Lip Enhancement

11.4.3.2.3. Facial Contouring

11.4.3.2.4. Glabellar Furrows

11.4.3.2.5. Peri-Orbital

11.4.3.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.4. Germany

11.4.4.1. Germany Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.4.1.1. HA Dermal Fillers

11.4.4.1.1.1. Monophasic HA Fillers

11.4.4.1.1.2. Biphasic HA Fillers

11.4.4.1.2. Non-HA Dermal Fillers

11.4.4.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.4.1.2.2. Collagen

11.4.4.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.4.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.4.2. Germany Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.4.2.1. Wrinkles

11.4.4.2.2. Lip Enhancement

11.4.4.2.3. Facial Contouring

11.4.4.2.4. Glabellar Furrows

11.4.4.2.5. Peri-Orbital

11.4.4.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.5. Italy

11.4.5.1. Italy Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.5.1.1. HA Dermal Fillers

11.4.5.1.1.1. Monophasic HA Fillers

11.4.5.1.1.2. Biphasic HA Fillers

11.4.5.1.2. Non-HA Dermal Fillers

11.4.5.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.5.1.2.2. Collagen

11.4.5.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.5.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.5.2. Italy Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.5.2.1. Wrinkles

11.4.5.2.2. Lip Enhancement

11.4.5.2.3. Facial Contouring

11.4.5.2.4. Glabellar Furrows

11.4.5.2.5. Peri-Orbital

11.4.5.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.6. Portugal

11.4.6.1. Portugal Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.6.1.1. HA Dermal Fillers

11.4.6.1.1.1. Monophasic HA Fillers

11.4.6.1.1.2. Biphasic HA Fillers

11.4.6.1.2. Non-HA Dermal Fillers

11.4.6.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.6.1.2.2. Collagen

11.4.6.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.6.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.6.2. Portugal Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.6.2.1. Wrinkles

11.4.6.2.2. Lip Enhancement

11.4.6.2.3. Facial Contouring

11.4.6.2.4. Glabellar Furrows

11.4.6.2.5. Peri-Orbital

11.4.6.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.7. Poland

11.4.7.1. Poland Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.7.1.1. HA Dermal Fillers

11.4.7.1.1.1. Monophasic HA Fillers

11.4.7.1.1.2. Biphasic HA Fillers

11.4.7.1.2. Non-HA Dermal Fillers

11.4.7.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.7.1.2.2. Collagen

11.4.7.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.7.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.7.2. Poland Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.7.2.1. Wrinkles

11.4.7.2.2. Lip Enhancement

11.4.7.2.3. Facial Contouring

11.4.7.2.4. Glabellar Furrows

11.4.7.2.5. Peri-Orbital

11.4.7.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.8. Nordic Countries

11.4.8.1. Nordic Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.8.1.1. HA Dermal Fillers

11.4.8.1.1.1. Monophasic HA Fillers

11.4.8.1.1.2. Biphasic HA Fillers

11.4.8.1.2. Non-HA Dermal Fillers

11.4.8.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.8.1.2.2. Collagen

11.4.8.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.8.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.8.2. Nordic Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.8.2.1. Wrinkles

11.4.8.2.2. Lip Enhancement

11.4.8.2.3. Facial Contouring

11.4.8.2.4. Glabellar Furrows

11.4.8.2.5. Peri-Orbital

11.4.8.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.8.3. Nordic Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

11.4.8.3.1. Denmark

11.4.8.3.2. Finland

11.4.8.3.3. Sweden

11.4.8.3.4. Iceland

11.4.8.3.5. Norway

11.4.8.3.6. Rest of Nordic

11.4.9. Ukraine

11.4.9.1. Ukraine Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.9.1.1. HA Dermal Fillers

11.4.9.1.1.1. Monophasic HA Fillers

11.4.9.1.1.2. Biphasic HA Fillers

11.4.9.1.2. Non-HA Dermal Fillers

11.4.9.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.9.1.2.2. Collagen

11.4.9.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.9.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.9.2. Ukraine Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.9.2.1. Wrinkles

11.4.9.2.2. Lip Enhancement

11.4.9.2.3. Facial Contouring

11.4.9.2.4. Glabellar Furrows

11.4.9.2.5. Peri-Orbital

11.4.9.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.10. The Benelux Union

11.4.10.1. The Benelux Union Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.10.1.1. HA Dermal Fillers

11.4.10.1.1.1. Monophasic HA Fillers

11.4.10.1.1.2. Biphasic HA Fillers

11.4.10.1.2. Non-HA Dermal Fillers

11.4.10.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.10.1.2.2. Collagen

11.4.10.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.10.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.10.2. The Benelux Union Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.10.2.1. Wrinkles

11.4.10.2.2. Lip Enhancement

11.4.10.2.3. Facial Contouring

11.4.10.2.4. Glabellar Furrows

11.4.10.2.5. Peri-Orbital

11.4.10.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.10.3. The Benelux Union Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

11.4.10.3.1. Wrinkles

11.4.10.3.2. Belgium

11.4.10.3.3. The Netherlands

11.4.10.3.4. Luxemburg

11.4.11. Rest of Europe

11.4.11.1. Rest of Europe Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.11.1.1. HA Dermal Fillers

11.4.11.1.1.1. Monophasic HA Fillers

11.4.11.1.1.2. Biphasic HA Fillers

11.4.11.1.2. Non-HA Dermal Fillers

11.4.11.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.11.1.2.2. Collagen

11.4.11.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.11.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.11.2. Rest of Europe Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.11.2.1. Wrinkles

11.4.11.2.2. Lip Enhancement

11.4.11.2.3. Facial Contouring

11.4.11.2.4. Glabellar Furrows

11.4.11.2.5. Peri-Orbital

11.4.11.2.6. Others (Scars, Crow’s Feet, Etc.)

11.5. Key Segment for Channeling Investments

11.5.1. By Country

11.5.2. By Type

11.5.3. By Application

12. Asia Pacific Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

12.1. Overview

12.1.1. Asia Pacific Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)

12.2. Asia Pacific Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.2.1. HA Dermal Fillers

12.2.1.1. Monophasic HA Fillers

12.2.1.2. Biphasic HA Fillers

12.2.2. Non-HA Dermal Fillers

12.2.2.1. Polymethylmethacrylate (PMMA) Filler

12.2.2.2. Collagen

12.2.2.3. Poly-L-Lactic Acid (PLLA)

12.2.2.4. Calcium Hydroxylapatite (CaHA)

12.3. Asia Pacific Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.3.1. Wrinkles

12.3.2. Lip Enhancement

12.3.3. Facial Contouring

12.3.4. Glabellar Furrows

12.3.5. Peri-Orbital

12.3.6. Others (Scars, Crow’s Feet, Etc.)

12.4. Asia Pacific Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

12.4.1. China

12.4.1.1. China Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.1.1.1. HA Dermal Fillers

12.4.1.1.1.1. Monophasic HA Fillers

12.4.1.1.1.2. Biphasic HA Fillers

12.4.1.1.2. Non-HA Dermal Fillers

12.4.1.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.1.1.2.2. Collagen

12.4.1.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.1.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.1.2. China Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.1.2.1. Wrinkles

12.4.1.2.2. Lip Enhancement

12.4.1.2.3. Facial Contouring

12.4.1.2.4. Glabellar Furrows

12.4.1.2.5. Peri-Orbital

12.4.1.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.2. Japan

12.4.2.1. Japan Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.2.1.1. HA Dermal Fillers

12.4.2.1.1.1. Monophasic HA Fillers

12.4.2.1.1.2. Biphasic HA Fillers

12.4.2.1.2. Non-HA Dermal Fillers

12.4.2.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.2.1.2.2. Collagen

12.4.2.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.2.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.2.2. Japan Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.2.2.1. Wrinkles

12.4.2.2.2. Lip Enhancement

12.4.2.2.3. Facial Contouring

12.4.2.2.4. Glabellar Furrows

12.4.2.2.5. Peri-Orbital

12.4.2.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.3. India

12.4.3.1. India Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.3.1.1. HA Dermal Fillers

12.4.3.1.1.1. Monophasic HA Fillers

12.4.3.1.1.2. Biphasic HA Fillers

12.4.3.1.2. Non-HA Dermal Fillers

12.4.3.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.3.1.2.2. Collagen

12.4.3.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.3.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.3.2. India Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.3.2.1. Wrinkles

12.4.3.2.2. Lip Enhancement

12.4.3.2.3. Facial Contouring

12.4.3.2.4. Glabellar Furrows

12.4.3.2.5. Peri-Orbital

12.4.3.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.4. Australia

12.4.4.1. Australia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.4.1.1. HA Dermal Fillers

12.4.4.1.1.1. Monophasic HA Fillers

12.4.4.1.1.2. Biphasic HA Fillers

12.4.4.1.2. Non-HA Dermal Fillers

12.4.4.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.4.1.2.2. Collagen

12.4.4.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.4.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.4.2. Australia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.4.2.1. Wrinkles

12.4.4.2.2. Lip Enhancement

12.4.4.2.3. Facial Contouring

12.4.4.2.4. Glabellar Furrows

12.4.4.2.5. Peri-Orbital

12.4.4.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.5. New Zealand

12.4.5.1. New Zealand Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.5.1.1. HA Dermal Fillers

12.4.5.1.1.1. Monophasic HA Fillers

12.4.5.1.1.2. Biphasic HA Fillers

12.4.5.1.2. Non-HA Dermal Fillers

12.4.5.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.5.1.2.2. Collagen

12.4.5.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.5.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.5.2. New Zealand Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.5.2.1. Wrinkles

12.4.5.2.2. Lip Enhancement

12.4.5.2.3. Facial Contouring

12.4.5.2.4. Glabellar Furrows

12.4.5.2.5. Peri-Orbital

12.4.5.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.6. Hong Kong

12.4.6.1. Hong Kong Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.6.1.1. HA Dermal Fillers

12.4.6.1.1.1. Monophasic HA Fillers

12.4.6.1.1.2. Biphasic HA Fillers

12.4.6.1.2. Non-HA Dermal Fillers

12.4.6.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.6.1.2.2. Collagen

12.4.6.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.6.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.6.2. Hong Kong Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.6.2.1. Wrinkles

12.4.6.2.2. Lip Enhancement

12.4.6.2.3. Facial Contouring

12.4.6.2.4. Glabellar Furrows

12.4.6.2.5. Peri-Orbital

12.4.6.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.7. Singapore

12.4.7.1. Singapore Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.7.1.1. HA Dermal Fillers

12.4.7.1.1.1. Monophasic HA Fillers

12.4.7.1.1.2. Biphasic HA Fillers

12.4.7.1.2. Non-HA Dermal Fillers

12.4.7.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.7.1.2.2. Collagen

12.4.7.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.7.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.7.2. Singapore Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.7.2.1. Wrinkles

12.4.7.2.2. Lip Enhancement

12.4.7.2.3. Facial Contouring

12.4.7.2.4. Glabellar Furrows

12.4.7.2.5. Peri-Orbital

12.4.7.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.8. Taiwan

12.4.8.1. Taiwan Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.8.1.1. HA Dermal Fillers

12.4.8.1.1.1. Monophasic HA Fillers

12.4.8.1.1.2. Biphasic HA Fillers

12.4.8.1.2. Non-HA Dermal Fillers

12.4.8.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.8.1.2.2. Collagen

12.4.8.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.8.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.8.2. Taiwan Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.8.2.1. Wrinkles

12.4.8.2.2. Lip Enhancement

12.4.8.2.3. Facial Contouring

12.4.8.2.4. Glabellar Furrows

12.4.8.2.5. Peri-Orbital

12.4.8.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.9. Malaysia

12.4.9.1. Malaysia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.9.1.1. HA Dermal Fillers

12.4.9.1.1.1. Monophasic HA Fillers

12.4.9.1.1.2. Biphasic HA Fillers

12.4.9.1.2. Non-HA Dermal Fillers

12.4.9.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.9.1.2.2. Collagen

12.4.9.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.9.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.9.2. Malaysia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.9.2.1. Wrinkles

12.4.9.2.2. Lip Enhancement

12.4.9.2.3. Facial Contouring

12.4.9.2.4. Glabellar Furrows

12.4.9.2.5. Peri-Orbital

12.4.9.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.10. Russia

12.4.10.1. Russia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.10.1.1. HA Dermal Fillers

12.4.10.1.1.1. Monophasic HA Fillers

12.4.10.1.1.2. Biphasic HA Fillers

12.4.10.1.2. Non-HA Dermal Fillers

12.4.10.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.10.1.2.2. Collagen

12.4.10.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.10.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.10.2. Russia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.10.2.1. Wrinkles

12.4.10.2.2. Lip Enhancement

12.4.10.2.3. Facial Contouring

12.4.10.2.4. Glabellar Furrows

12.4.10.2.5. Peri-Orbital

12.4.10.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.11. Southeast Asia

12.4.11.1. Southeast Asia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.11.1.1. HA Dermal Fillers

12.4.11.1.1.1. Monophasic HA Fillers

12.4.11.1.1.2. Biphasic HA Fillers

12.4.11.1.2. Non-HA Dermal Fillers

12.4.11.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.11.1.2.2. Collagen

12.4.11.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.11.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.11.2. Southeast Asia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.11.2.1. Wrinkles

12.4.11.2.2. Lip Enhancement

12.4.11.2.3. Facial Contouring

12.4.11.2.4. Glabellar Furrows

12.4.11.2.5. Peri-Orbital

12.4.11.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.12. Rest of Asia Pacific

12.4.12.1. Rest of Asia Pacific Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.12.1.1. HA Dermal Fillers

12.4.12.1.1.1. Monophasic HA Fillers

12.4.12.1.1.2. Biphasic HA Fillers

12.4.12.1.2. Non-HA Dermal Fillers

12.4.12.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.12.1.2.2. Collagen

12.4.12.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.12.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.12.2. Rest of Asia Pacific Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.12.2.1. Wrinkles

12.4.12.2.2. Lip Enhancement

12.4.12.2.3. Facial Contouring

12.4.12.2.4. Glabellar Furrows

12.4.12.2.5. Peri-Orbital

12.4.12.2.6. Others (Scars, Crow’s Feet, Etc.)

12.5. Key Segment for Channeling Investments

12.5.1. By Country

12.5.2. By Type

12.5.3. By Application

13. Middle East and Africa Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

13.1. Overview

13.1.1. Middle East and Africa Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)

13.2. Middle East and Africa Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

13.2.1. HA Dermal Fillers

13.2.1.1. Monophasic HA Fillers

13.2.1.2. Biphasic HA Fillers

13.2.2. Non-HA Dermal Fillers

13.2.2.1. Polymethylmethacrylate (PMMA) Filler

13.2.2.2. Collagen

13.2.2.3. Poly-L-Lactic Acid (PLLA)

13.2.2.4. Calcium Hydroxylapatite (CaHA)

13.3. Middle East and Africa Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

13.3.1. Wrinkles

13.3.2. Lip Enhancement

13.3.3. Facial Contouring

13.3.4. Glabellar Furrows

13.3.5. Peri-Orbital

13.3.6. Others (Scars, Crow’s Feet, Etc.)

13.4. Middle East and Africa Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

13.4.1. GCC Countries

13.4.1.1. GCC Countries Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

13.4.1.1.1. HA Dermal Fillers

13.4.1.1.1.1. Monophasic HA Fillers

13.4.1.1.1.2. Biphasic HA Fillers

13.4.1.1.2. Non-HA Dermal Fillers

13.4.1.1.2.1. Polymethylmethacrylate (PMMA) Filler

13.4.1.1.2.2. Collagen

13.4.1.1.2.3. Poly-L-Lactic Acid (PLLA)

13.4.1.1.2.4. Calcium Hydroxylapatite (CaHA)

13.4.1.2. GCC Countries Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

13.4.1.2.1. Wrinkles

13.4.1.2.2. Lip Enhancement

13.4.1.2.3. Facial Contouring

13.4.1.2.4. Glabellar Furrows

13.4.1.2.5. Peri-Orbital

13.4.1.2.6. Others (Scars, Crow’s Feet, Etc.)

13.4.2. UAE

13.4.2.1. UAE Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

13.4.2.1.1. HA Dermal Fillers

13.4.2.1.1.1. Monophasic HA Fillers

13.4.2.1.1.2. Biphasic HA Fillers

13.4.2.1.2. Non-HA Dermal Fillers

13.4.2.1.2.1. Polymethylmethacrylate (PMMA) Filler

13.4.2.1.2.2. Collagen

13.4.2.1.2.3. Poly-L-Lactic Acid (PLLA)

13.4.2.1.2.4. Calcium Hydroxylapatite (CaHA)

13.4.2.2. UAE Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

13.4.2.2.1. Wrinkles

13.4.2.2.2. Lip Enhancement

13.4.2.2.3. Facial Contouring

13.4.2.2.4. Glabellar Furrows

13.4.2.2.5. Peri-Orbital

13.4.2.2.6. Others (Scars, Crow’s Feet, Etc.)

13.4.3. Saudi Arabia

13.4.3.1. Saudi Arabia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

13.4.3.1.1. HA Dermal Fillers

13.4.3.1.1.1. Monophasic HA Fillers

13.4.3.1.1.2. Biphasic HA Fillers

13.4.3.1.2. Non-HA Dermal Fillers

13.4.3.1.2.1. Polymethylmethacrylate (PMMA) Filler

13.4.3.1.2.2. Collagen

13.4.3.1.2.3. Poly-L-Lactic Acid (PLLA)

13.4.3.1.2.4. Calcium Hydroxylapatite (CaHA)

13.4.3.2. Saudi Arabia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

13.4.3.2.1. Wrinkles

13.4.3.2.2. Lip Enhancement

13.4.3.2.3. Facial Contouring

13.4.3.2.4. Glabellar Furrows

13.4.3.2.5. Peri-Orbital

13.4.3.2.6. Others (Scars, Crow’s Feet, Etc.)

13.4.4. Southern Africa

13.4.4.1. Southern Africa Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

13.4.4.1.1. HA Dermal Fillers

13.4.4.1.1.1. Monophasic HA Fillers

13.4.4.1.1.2. Biphasic HA Fillers

13.4.4.1.2. Non-HA Dermal Fillers

13.4.4.1.2.1. Polymethylmethacrylate (PMMA) Filler

13.4.4.1.2.2. Collagen

13.4.4.1.2.3. Poly-L-Lactic Acid (PLLA)

13.4.4.1.2.4. Calcium Hydroxylapatite (CaHA)

13.4.4.2. Southern Africa Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

13.4.4.2.1. Wrinkles

13.4.4.2.2. Lip Enhancement

13.4.4.2.3. Facial Contouring

13.4.4.2.4. Glabellar Furrows

13.4.4.2.5. Peri-Orbital

13.4.4.2.6. Others (Scars, Crow’s Feet, Etc.)

13.4.5. Rest of MEA

13.4.5.1. Rest of MEA Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

13.4.5.1.1. HA Dermal Fillers

13.4.5.1.1.1. Monophasic HA Fillers

13.4.5.1.1.2. Biphasic HA Fillers

13.4.5.1.2. Non-HA Dermal Fillers

13.4.5.1.2.1. Polymethylmethacrylate (PMMA) Filler

13.4.5.1.2.2. Collagen

13.4.5.1.2.3. Poly-L-Lactic Acid (PLLA)

13.4.5.1.2.4. Calcium Hydroxylapatite (CaHA)

13.4.5.2. Rest of MEA Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

13.4.5.2.1. Wrinkles

13.4.5.2.2. Lip Enhancement

13.4.5.2.3. Facial Contouring

13.4.5.2.4. Glabellar Furrows

13.4.5.2.5. Peri-Orbital

13.4.5.2.6. Others (Scars, Crow’s Feet, Etc.)

13.5. Key Segment for Channeling Investments

13.5.1. By Country

13.5.2. By Type

13.5.3. By Application

14. Latin America Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

14.1. Overview

14.1.1. Latin America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)

14.2. Latin America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

14.2.1. HA Dermal Fillers

14.2.1.1. Monophasic HA Fillers

14.2.1.2. Biphasic HA Fillers

14.2.2. Non-HA Dermal Fillers

14.2.2.1. Polymethylmethacrylate (PMMA) Filler

14.2.2.2. Collagen

14.2.2.3. Poly-L-Lactic Acid (PLLA)

14.2.2.4. Calcium Hydroxylapatite (CaHA)

14.3. Latin America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

14.3.1. Wrinkles

14.3.2. Lip Enhancement

14.3.3. Facial Contouring

14.3.4. Glabellar Furrows

14.3.5. Peri-Orbital

14.3.6. Others (Scars, Crow’s Feet, Etc.)

14.4. Latin America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

14.4.1. Brazil

14.4.1.1. Brazil Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

14.4.1.1.1. HA Dermal Fillers

14.4.1.1.1.1. Monophasic HA Fillers

14.4.1.1.1.2. Biphasic HA Fillers

14.4.1.1.2. Non-HA Dermal Fillers

14.4.1.1.2.1. Polymethylmethacrylate (PMMA) Filler

14.4.1.1.2.2. Collagen

14.4.1.1.2.3. Poly-L-Lactic Acid (PLLA)

14.4.1.1.2.4. Calcium Hydroxylapatite (CaHA)

14.4.1.2. Brazil Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

14.4.1.2.1. Wrinkles

14.4.1.2.2. Lip Enhancement

14.4.1.2.3. Facial Contouring

14.4.1.2.4. Glabellar Furrows

14.4.1.2.5. Peri-Orbital

14.4.1.2.6. Others (Scars, Crow’s Feet, Etc.)

14.4.2. Argentina

14.4.2.1. Argentina Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

14.4.2.1.1. HA Dermal Fillers

14.4.2.1.1.1. Monophasic HA Fillers

14.4.2.1.1.2. Biphasic HA Fillers

14.4.2.1.2. Non-HA Dermal Fillers

14.4.2.1.2.1. Polymethylmethacrylate (PMMA) Filler

14.4.2.1.2.2. Collagen

14.4.2.1.2.3. Poly-L-Lactic Acid (PLLA)

14.4.2.1.2.4. Calcium Hydroxylapatite (CaHA)

14.4.2.2. Argentina Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

14.4.2.2.1. Wrinkles

14.4.2.2.2. Lip Enhancement

14.4.2.2.3. Facial Contouring

14.4.2.2.4. Glabellar Furrows

14.4.2.2.5. Peri-Orbital

14.4.2.2.6. Others (Scars, Crow’s Feet, Etc.)

14.4.3. Rest of Latin America

14.4.3.1. Rest of Latin America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

14.4.3.1.1. HA Dermal Fillers

14.4.3.1.1.1. Monophasic HA Fillers

14.4.3.1.1.2. Biphasic HA Fillers

14.4.3.1.2. Non-HA Dermal Fillers

14.4.3.1.2.1. Polymethylmethacrylate (PMMA) Filler

14.4.3.1.2.2. Collagen

14.4.3.1.2.3. Poly-L-Lactic Acid (PLLA)

14.4.3.1.2.4. Calcium Hydroxylapatite (CaHA)

14.4.3.2. Rest of Latin America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

14.4.3.2.1. Wrinkles

14.4.3.2.2. Lip Enhancement

14.4.3.2.3. Facial Contouring

14.4.3.2.4. Glabellar Furrows

14.4.3.2.5. Peri-Orbital

14.4.3.2.6. Others (Scars, Crow’s Feet, Etc.)

14.5. Key Segment for Channeling Investments

14.5.1. By Country

14.5.2. By Type

14.5.3. By Application

15. Competitive Benchmarking

15.1. Player Positioning Analysis

15.2. Global Presence and Growth Strategies

16. Player Profiles

16.1. Allergan Plc.

16.1.1. Company Details

16.1.2. Company Overview

16.1.3. Product Offerings

16.1.4. Key Developments

16.1.5. Financial Analysis

16.1.6. SWOT Analysis

16.1.7. Business Strategies

16.2. Bloomage BioTechnology Corporation Limited

16.2.1. Company Details

16.2.2. Company Overview

16.2.3. Product Offerings

16.2.4. Key Developments

16.2.5. Financial Analysis

16.2.6. SWOT Analysis

16.2.7. Business Strategies

16.3. Bohus BioTech AB

16.3.1. Company Details

16.3.2. Company Overview

16.3.3. Product Offerings

16.3.4. Key Developments

16.3.5. Financial Analysis

16.3.6. SWOT Analysis

16.3.7. Business Strategies

16.4. Matex Lab SA (Neauvia)

16.4.1. Company Details

16.4.2. Company Overview

16.4.3. Product Offerings

16.4.4. Key Developments

16.4.5. Financial Analysis

16.4.6. SWOT Analysis

16.4.7. Business Strategies

16.5. DR. Korman

16.5.1. Company Details

16.5.2. Company Overview

16.5.3. Product Offerings

16.5.4. Key Developments

16.5.5. Financial Analysis

16.5.6. SWOT Analysis

16.5.7. Business Strategies

16.6. Sinclair Pharma

16.6.1. Company Details

16.6.2. Company Overview

16.6.3. Product Offerings

16.6.4. Key Developments

16.6.5. Financial Analysis

16.6.6. SWOT Analysis

16.6.7. Business Strategies

16.7. Galderma S.A.

16.7.1. Company Details

16.7.2. Company Overview

16.7.3. Product Offerings

16.7.4. Key Developments

16.7.5. Financial Analysis

16.7.6. SWOT Analysis

16.7.7. Business Strategies

16.8. Hangzhou Singclean Medical Products Co.,Ltd

16.8.1. Company Details

16.8.2. Company Overview

16.8.3. Product Offerings

16.8.4. Key Developments

16.8.5. Financial Analysis

16.8.6. SWOT Analysis

16.8.7. Business Strategies

16.9. LG Lifesciences

16.9.1. Company Details

16.9.2. Company Overview

16.9.3. Product Offerings

16.9.4. Key Developments

16.9.5. Financial Analysis

16.9.6. SWOT Analysis

16.9.7. Business Strategies

16.10.   Luminera Derm Ltd

16.10.1. Company Details

16.10.2. Company Overview

16.10.3. Product Offerings

16.10.4. Key Developments

16.10.5. Financial Analysis

16.10.6. SWOT Analysis

16.10.7. Business Strategies

16.11.   Merz Pharma

16.11.1. Company Details

16.11.2. Company Overview

16.11.3. Product Offerings

16.11.4. Key Developments

16.11.5. Financial Analysis

16.11.6. SWOT Analysis

16.11.7. Business Strategies

16.12.   SciVision Biotech Inc.

16.12.1. Company Details

16.12.2. Company Overview

16.12.3. Product Offerings

16.12.4. Key Developments

16.12.5. Financial Analysis

16.12.6. SWOT Analysis

16.12.7. Business Strategies

16.13.   Suneva Medical, Inc.

16.13.1. Company Details

16.13.2. Company Overview

16.13.3. Product Offerings

16.13.4. Key Developments

16.13.5. Financial Analysis

16.13.6. SWOT Analysis

16.13.7. Business Strategies

16.14.   TEOXANE Laboratories

16.14.1. Company Details

16.14.2. Company Overview

16.14.3. Product Offerings

16.14.4. Key Developments

16.14.5. Financial Analysis

16.14.6. SWOT Analysis

16.14.7. Business Strategies

17. Key Findings

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.   

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology


 

  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 0

    Filename: pages/reportpage.php

    Line Number: 163

    Backtrace:

    File: /var/www/html/ami/application/views/pages/reportpage.php
    Line: 163
    Function: _error_handler

    File: /var/www/html/ami/application/controllers/Report.php
    Line: 153
    Function: view

    File: /var/www/html/ami/index.php
    Line: 315
    Function: require_once